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Abstract
Objective—To determine if exposure to DBPs during gestation increases the risk of adverse birth
outcomes, specifically term small for gestational age (SGA) birth, preterm birth (PTB), and very
PTB (<32 weeks gestation).
Methods—We used weekly measurements total trihalomethanes (TTHMs), 5 haloacetic acids
(HAA5), and total organic halides (TOX) collected from two distribution systems to evaluate the
associations between DBP concentrations and term SGA, PTB and very PTB using logistic
regression.
Results—We found no associations between DBPs and term-SGA. In the site with higher
concentrations of bromine-containing DBPs, we found an association between TOX and PTB; this
association was larger, though less precise, for very PTB.
Conclusions—Our results do not support an association between TTHMs or HAA5 and the
birth outcomes investigated, but an association was found between increased TOX and PTB.
Introduction
Chlorine, used to disinfect drinking water, reacts with natural organic matter in water,
resulting in the formation of a complex mixture of disinfection by-products (DBPs),
including trihalomethanes (THMs), haloacetic acids (HAAs), and other halogenated
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organics. Total THM (TTHM) is an aggregate measure of the 4 most commonly found
trihalomethane species: chloroform (CHCl3), bromodichloromethane (BrCl2CH),
dibromochloromethane (Br2ClCH) and bromoform (CHBr3). Total organic halide (TOX) is
sometimes used as a surrogate measure of all halogen-containing DBPs, some of which were
first discovered in drinking water over 36 years ago.1,2 DBPs form during water disinfection
and the proportional distributions of individual chemicals within a class and across classes
can vary by source water quality and by distribution systems, resulting in a gradient of
concentrations.3 A variety of factors influence DBP formation, including organic precursor
type, precursor concentration, chlorine dosage, temperature, pH, bromide concentrations and
reaction time.4,5
A sizable body of research has accumulated addressing the potential reproductive toxicity of
DBPs. A recent comprehensive review of this topic has reported inconsistent associations
with a wide range of outcomes, including spontaneous abortion, stillbirth, birth defects,
preterm birth, and reduced birth weight.6 This review identifies exposure assessment as the
principal limitation to epidemiologic studies of DBPs and adverse pregnancy outcomes. A
recent meta-analysis suggests possible evidence of association between DBPs and SGA, but
little to no evidence of association between DBPs and the birth outcomes of low birth weight
and preterm delivery.7 Additional studies have provided support for an association between
exposure to TTHMs and stillbirths,8,9 fetal growth restriction,10–13 and preterm
delivery.10,12,14 Other studies have generated evidence against such associations for some
adverse pregnancy outcomes, including preterm delivery15 and pregnancy loss16.
In most epidemiologic studies, the exposure assessment is based on concentrations from one
or two samples available from the public water utility monitoring data during the period of
etiologic interest. Such an approach can lead to significant misclassification of exposure
depending on the degree of temporal and spatial variation in DBP concentrations across the
water distribution system.17–20 Through a previously conducted study, we have information
on DBP concentrations available from weekly or biweekly measurements of water samples
at three geographic sites in the Southern US. The three study sites were selected to reflect a
range of DBP exposure profiles across sites and speciation typical of those found across the
US. One site had moderate levels of chlorinated DBPs (referred to here as the “chlorinated
DBP site”), one had moderate levels of brominated DBPs (“brominated DBP site”), and one
had low levels of all DBPs (“low DBP site”).
A series of recent publications utilized these DBP data to characterize the risk of small-for-
gestational-age (SGA), preterm-birth (PTB), and low birth weight (LBW) among term births
in a cohort of women from these three communities while they were planning to become
pregnant or early in pregnancy (≤12 weeks).15,21 The results of these studies did not suggest
an adverse effect of DBPs on PTB or LBW, and an association of TTHMs with SGA was
observed only for the small number of participants with average residential TTHM
concentrations above the current regulatory standard of 80 μg/L. Women who volunteered
to participate in the study were not a random or necessarily representative sample of the
general female population and thus these results may not be generalizable to all of the
women in these communities. In the chlorinated DBP site, study participants were more
highly educated, more likely to be non-Hispanic white, less likely to be Hispanic, and more
likely to be nulliparous than the general population. Age was similar in study participants
and the overall population at this site. In the brominated DBP site, participants were more
likely to be Hispanic and more likely to be nulliparous than the general population. The
study participants and overall female population were similar in age and education level in
this site.22 Our objective was to use weekly exposure data from the previous study and
publicly available vital records data, which eliminate the concern with selective participation
and markedly expands the study size, to evaluate whether women exposed to higher
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concentrations of DBPs during specific periods of gestation have increased risk of adverse
birth outcomes, specifically term-SGA, PTB, and very PTB.
Methods
Subjects
This study was approved by the University of North Carolina School of Public Health's
Institutional Review Board. We obtained birth records with addresses at date of birth that
had ZIP codes that were included within the boundary of the water distribution area to
maximize likelihood of water measures representing home concentrations of the women.
The sampling strategy included one group of births from a site with moderate levels of
chlorine-containing DBPs and lower levels of bromine-containing DBPs (the “chlorinated”
DBP site) and one group from a site with moderate levels of bromine-containing DBPs and
lower levels of chlorine-containing DBPs (the “brominated” DBP site). (There were three
sites considered in Hoffman et al.,15,21 but the third site (low DBP site) was not considered
in this analysis due to extremely low exposure levels such that within-site comparisons are
uninformative but regional demographic differences render the site susceptible to bias as a
low-exposure referent.) The term “moderate” is used here to describe exposures that
approach but are still below the limits established by the U.S. EPA for regulated DBPs (i.e.,
80 μg/L TTHM and 60 μg/L HAA5).23 There were 27,062 births in the chlorinated DBP
site during the study period and in the target ZIP codes. There were 3,946 births in the
brominated DBP site during the study period and in the target ZIP codes. Table 1 gives
descriptive statistics of the variables for both sites.
Exposure Data and Assignment
Our investigation made use of exposure data collected for a previous study. The water
sampling and analytic methodologies from this study have been described previously.16,22
Water was sampled at weekly intervals at a representative location in each of the study sites
and analyzed for TTHM, the sum of 9 HAA species (HAA9) and TOX (Table 2). Samples
were periodically collected at several points in the distribution system to verify that the
sampling locations chosen had TTHM, HAA and TOX concentrations that were indeed
representative of the entire system on that day. Because the sites used combined chlorine as
a terminal disinfectant, very little spatial variability in DBP concentration was observed on
any given day. The addition of ammonia to chlorinated water to form monochloramine is a
widely accepted water treatment practice to control the regulated DBPs because
monochloramine does not form THMs and HAAs to any appreciable degree. Additionally,
monochloramine forms much lower levels of TOX than free chlorine. Sample collection was
performed by field personnel in accordance with a specified protocol. Residual chlorine
concentrations and temperature were also measured at the time of DBP sample collection.
Samples were collected near midday from a cold water tap that had been run for at least 5
minutes before sample collection. Weekly tap water samples were collected from the
chlorinated DBP site between October 10, 2000 and February 29, 2004, and from the
brominated DBP site between June 3, 2002 and September 5, 2004.
Continuous and categorized forms of the water quality variables were used in the analysis.
Categorization was created using the minimum, 50th percentile, 75th percentile, 90th
percentile, and the maximum of the exposures over the time of water collection for each site
separately (Table 3). Third trimester exposures were used in the term-SGA analysis whereas
second trimester exposures were used in the PTB and very PTB analyses. Third trimester
exposure averages include data up to time of birth. Since the two sites used in these analyses
were chosen for the relative contribution of chlorine- and bromine-containing DBPs, all
these DBPs in the two sites were categorized as indicated above for categorical analysis
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(Table 3). For this study, the sum of five haloacetic acids (HAA5) includes ClAA, Cl2AA,
Cl3AA, BrAA and Br2AA. HAA5 was used in this analysis for comparability with results
from Hoffman et al.15,21 and EPA standards.23 HAA9 was considered in the analysis of
term-SGA, PTB, and very PTB and results were similar to those for HAA5 (see Table,
Supplemental Digital Content 1, http://links.lww.com/JOM/A67, which gives odds ratios
and confidence intervals for HAA9 by site). We also evaluated the “unaccounted” portion of
TOX; that is we subtracted the sum of THM4 and HAA9 (when converted to TOX as Cl)
from the TOX variable in order to evaluate whether the non-THM and non-HAA species of
TOX were more or less strongly associated with the adverse birth outcomes being
investigated. In all categorical analyses, the lowest level of exposure was used as the
referent group.
Statistical Analysis
The analysis used covariates available in birth records data that may be related to the birth
outcomes of interest, including maternal age, maternal race, marital status, maternal
education level, tobacco use, alcohol use, and parity. Three response variables were
considered: term-SGA, PTB, and very PTB. Birth weight as a continuous measure was also
evaluated and yielded results similar to those for term-SGA (see see Table, Supplemental
Digital Content 2, http://links.lww.com/JOM/A68, which illustrates the change in birth
weight associated with DBP exposure). PTB was defined as birth at less than 37 weeks of
gestation; very PTB was defined as birth at less than 32 weeks of gestation, and term-SGA
was created for infants who were non-Hispanic white, non-Hispanic black, and Hispanic
based on the availability of published data for these three groups. The cut-points used to
define term-SGA were the 10th percentiles from Overpeck et al.24 for non-Hispanic White
and Hispanic mothers, and the cut-points for non-Hispanic Black mothers come from Zhang
and Bowes.25 The race variable created for the SGA analysis was used in the PTB and very
PTB analyses. Only births of 37 to 42 weeks of gestation were used in the term-SGA
analysis.
The association between DBP concentrations and the three responses of interest (term-SGA,
PTB, and very PTB) were assessed using logistic regression in SAS.V9.1 (SAS Institute,
Cary, NC). Results with a p-value less than 0.05 were considered statistically significant. In
the brominated DBP site, 20.7% of birth records used in the analysis did not include a value
for parity. Multiple imputations were implemented using PROC MI in SAS (SAS Institute,
Cary, NC) for parity.26 Five imputations were created for evaluation. Imputations were
carried out as if variables were continuous to reduce bias.27 When modeling term-SGA,
PTB, and very PTB, the imputed continuous parity variable was used, but to compute term-
SGA values the parity values were rounded. Logistic regression was used to assess the
association between term-SGA, PTB, and very PTB, while accounting for the five sets of
multiple imputations, using PROC MIANALYZE (SAS Institute, Cary, NC).
Results
Table 4 presents the odds ratios and 95% confidence intervals for the categorical and
continuous exposure variables for SGA, PTB and very PTB among the births occurring in
the chlorinated DBP site. The three primary measures of DBPs were unrelated to term-SGA,
PTB or very PTB for the chlorinated DBP site.
Table 5 presents the odds ratios and 95% confidence intervals for the categorical and
continuous exposure variables for term-SGA, PTB and very PTB among the births occurring
in the brominated DBP site. In the brominated DBP site, there was little indication of an
exposure-response relationship of TTHM or HAA5 with any of the pregnancy outcomes.
However, both categorical and continuous TOX indicated an increased risk of PTB with
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increased exposure. Categorical and continuous TOX both suggest a markedly increased risk
of very PTB with increased exposure, but the four-fold increase in risk for very PTB when
those with the highest group of TOX exposure were compared to those with the lowest was
based on just 3 cases.
Table 6 presents the odds ratios and 95% confidence intervals for the aggregated chlorinated
and brominated DBP exposure variables for term-SGA, PTB and very PTB among the births
occurring in the chlorinated and brominated DBP sites. While there was some evidence for
an increased association for very PTB for both the categorized chlorine- and bromine-
containing DBP exposure variables in the brominated DBP site, there was no evident
exposure-response pattern for either of the exposure variables.
Table 7 gives odds ratios and 95% confidence intervals for the “unaccounted” TOX DBP
exposures. In the chlorinated site, there was an increased odds of PTB with increased levels
of continuous “unaccounted” TOX. Also, there is an increased odds of very PTB for the
higher level of categorical “unaccounted” TOX for the chlorinated site. In the brominated
site, for both continuous and categorized forms of “unaccounted” TOX, there is an increased
odds of PTB and very PTB. Generally, the results for the “unaccounted” TOX were similar
to those for TOX.
Discussion
The water distribution systems in the two sites are characterized by a larger relative
contribution of either chlorine- or bromine-containing DBPs. We conducted within-site
analyses that separated the chlorine-containing THMs and HAAs from the bromine-
containing THMs and HAAs into separate groups. Overall, we report no associations in the
chlorinated and brominated DBP sites between DBPs and term-SGA. In the brominated
DBP site we found positive associations between higher concentrations of TOX and PTB
and very PTB, with the latter showing large but very imprecise measures of association.
Previous studies have reported a moderately increased risk of delivering an SGA infant
among women exposed to high levels of TTHM,12–14,21,28,29 while others have found no
association.11,30 Porter et al.30 found an increased risk of intrauterine growth retardation for
subjects exposed to higher levels of HAA5 in the third trimester. Hoffman et al.21 reported
some evidence of an association between increasing TTHM exposure and increasing risk of
SGA birth in the chlorinated DBP site but not in the brominated DBP site and evidence of
increased HAA5 exposure and increased risk of SGA birth in the brominated DBP site but
not in the chlorinated DBP site. They found no association between TOX exposure and
SGA. We found no associations in either site between any exposures and term-SGA. These
differences likely reflect differences in the recruited subjects used by Hoffman et al. and
those in the general population, as well as differences in the type and quality of the data used
in the our analyses and the analyses by Hoffman et al. Whereas Hoffman et al. had much
more detailed information on the study participants, our study population is much larger and
less susceptible to bias related to self-selection for participation (i.e., planned pregnancies,
motivation to participate in research).
There is little evidence from previous studies to suggest an association between DBPs and
PTB.12,15,18,28,29,31,32 Studies examining the association between TTHM and preterm birth
generally have indicated no association, with estimated relative risks for preterm birth
ranging between 0.7 and 1.2 and no notable exposure-response trends.12,15,18,28,29,31,32
However a modest inverse relationship between TTHM and preterm birth (i.e., lower risk
with higher exposure) was reported in recent studies by Wright et al.12, Hoffman et al.15,
and Lewis et al.33 Similarly, our results show a lack of association with TTHM and the
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outcomes of interest. Hoffman et al.15 reported an absence of an association between both
HAA5 and TOX exposure and PTB. We also examined the association of HAA5 and TOX
concentrations with both PTB and very PTB, and found the strongest association for TOX
and very PTB in the brominated DBP site. Our results indicating an association between
TOX and very PTB in the brominated DBP site are novel, as few studies have examined the
association between DBPs and very PTB as an outcome. It is possible that there is less
misclassification in very PTB than PTB, and that this could account for the observed effect
for very PTB and the weaker association observed in our study and the lack of an
association observed in previous investigations for PTB. Alternately, these results could be
due to chance or confounding.
We used term-SGA as a surrogate for fetal growth restriction because it is conventionally
used to identify more severe growth restriction in epidemiologic research and has been
examined in previous DBP studies. However, not all infants who are small at birth are
growth-restricted and vice-versa. The use of term-SGA as a surrogate for fetal growth
restriction may be a limitation in our study and in many other epidemiologic evaluations
concerned with fetal growth. Analyses of birth weight as a continuous measure yielded
similar patterns as were found for term-SGA (see see Table, Supplemental Digital Content
2, http://links.lww.com/JOM/A68, which illustrates the change in birth weight associated
with DBP exposure).
The strong relationship between residential location (i.e. study site) and tap water DBP
concentration in our study is a strength for the internal comparisons (within-site) that we
have made, but a limitation in that analyses that integrate across sites are susceptible to
confounding by population characteristics. By design, and because the sites used combined
chlorine as a terminal disinfectant to reduce spatial variability, exposure differences within
sites occur solely due to temporal differences in tap water concentrations. Thus, by limiting
the study to within-site analyses, only attributes that might covary with time of pregnancy
(e.g., seasonal illnesses or variation in physical activity) could be potential confounders.
A limitation to our study is the lack of a completely unexposed reference group, so that we
are only able to examine variation within the range that was present. This was a limitation of
a previous study which did not find an association between PTB and TTHMs and for several
previous studies that examined HAAs.29 Adverse pregnancy outcomes associated with low
DBP concentrations (down to 5 μg/L BDCM and 20 μg/L TTHM) have been suggested in
other studies. Therefore if effects do occur at those levels, including low or unexposed
individuals in the referent group (up to ~60 μg/L TTHM in our study) would limit our
ability to discern differences in risk related to the truncated range of exposure we were able
to examine.
Our study is strengthened by the concurrent measurement of DBP concentrations over the
course of pregnancy, which included weekly DBP measurements collected to capture
temporal variability in DBP concentrations and allowed estimation of trimester-specific
average exposures based on more measurements (generally 12–13) made at regular intervals
rather than the typical case of 1 day of monitoring during a 3-month period. Validation of
this water sampling strategy ensured that the concentrations throughout the water
distribution systems serving the study participants' homes are accurately represented,
thereby reducing spatial variability in exposure during any given week.22 The resulting
assignment of residential DBP concentrations averaged over a trimester should be more
accurate than in previous studies.
In conclusion, our results provide evidence against an association of DBP measures with
adverse birth outcomes, with the possible exception of TOX and PTB and very PTB in the
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brominated site. Additional research to disentangle the effects of specific individual DBPs or
groups of DBPs, specifically TOX, is warranted.
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Table 1
Water exposure data (Analysis dataset)
Chlorinated DBP site Brominated DBP site
N % N %
Small for gestational age
 term, SGA 1667 6.1 247 6.3
 term, not SGA 21781 80.1 2662 67.5
 preterm 2201 8.1 438 11.1
 Missing 1528 5.6 599 15.2
Preterm birth
 Preterm 2201 8.1 438 11.1
 not Preterm 24976 91.9 3508 88.9
 Missing 0 0 0 0
Very preterm birth
 Very preterm 381 1.4 83 2.1
 not Very preterm 26796 98.6 3863 97.9
 Missing 0 0 0 0
Maternal age
 <20 1760 6.5 624 15.8
 20–24 5100 18.8 1257 31.7
 25–29 7333 27.0 1042 26.4
 30–34 8392 31.0 675 17.1
 35–39 3859 14.2 281 7.1
 >=40 733 2.7 67 1.7
 Missing 0 0 0 0
Maternal race
 White, Non-Hispanic 14308 52.7 1528 38.7
 Black, Non-Hispanic 6756 24.9 916 23.2
 Hispanic 4477 16.5 1366 34.6
 Missing/Other 1636 6.0 136 3.4
Marital status
 Married 19560 72.0 1844 46.7
 Not married 7617 28.0 1807 45.8
 Missing 0 0 295 7.5
Highest education attained
 High school 9515 35.0 2550 64.6
 Some college 4968 18.3 788 20
 College degree or more 12613 46.4 589 14.9
 Missing 81 0.3 19 0.5
Tobacco use
 Yes 1343 4.9 328 8.3
 No 25819 95.0 3326 84.3
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Chlorinated DBP site Brominated DBP site
N % N %
 Missing 15 0.1 292 7.4
Alcohol use
 Yes 128 0.5 74 1.9
 No 27028 99.5 3580 90.7
 Missing 21 0.1 292 7.4
Parity
 Nulliparous 12093 44.5 1407 35.7
 Parous 15075 55.5 1724 43.7
 Missing 9 0.0 815 20.7
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Table 2
Average Residential DBP Concentrations (μg/L) in the chlorinated and brominated DBP sites
DBP Chlorinated DBP site Mean (SD) Brominated DBP site Mean (SD)
Trihalomethanes
 Chloroform (CHCl3) 45.6 (19.7) 11.9 (7.5)
 Bromodichloromethane (BrCl2CH) 13.8 (4.9) 19.7 (6.8)
 Dibromochloromethane (Br2ClCH) 3.9 (2.1) 22.4 (8.1)
 Bromoform (CHBr3) 0.1 (0.3) 6.5 (5.1)
 TTHM
a 63.3 (23.1) 60.4 (20.7)
Haloacetic acids
 Chloroacetic acid (ClAA) 2.4 (1.9) 2.4 (2.5)
 Dichloroacetic acid (Cl2AA) 17.5 (5.7) 6.6 (3.1)
 Trichloroacetic acid (Cl3AA) 12.5 (6.1) 4.7 (3.2)
 Bromochloroacetic acid (BrClAA) 4.1 (1.7) 8.1 (1.8)
 Bromodichloroacetic acid (BrCl2AA) 4.4 (2.0) 8.3 (2.8)
 Dibromochloroacetic acid (Br2ClAA) 1.3 (1.2) 5.5 (1.8)
 Bromoacetic acid (BrAA) 0.1 (0.2) 0.8 (0.9)
 Dibromoacetic acid (Br2AA) 0.7 (0.8) 6.9 (3.2)
 Tribromoacetic acid (Br3AA) 0.2 (0.7) 2.5 (1.6)
 HAA5
b 33.2 (12.1) 21.5 (5.9)
 HAA9
c 43.2 (14.4) 45.7 (9.0)
Total organic halides (TOX) 170.8 (32.3) 186.1 (35.1)
Unaccounted TOX 95.7 (25.7) 127.7 (32.7)
Chlorinated DBPs
d 105.4 (33.9) 89.6 (24.2)
Brominated DBPs
e 28.6 (9.9) 80.5 (21.0)
a
TTHM is the sum of the 4 THM species
b
HAA5 is the sum of ClAA, Cl2AA, Cl3AA, BrAA, and Br2AA
c
HAA9 is the sum of the 9 haloacetic acid species
d
Chlorinated DBPs are the sum of CHCl3, BrCl2CH, Br2ClCH, ClAA, Cl2AA, Cl3AA, BrClAA, BrCl2AA, Br2ClAA
e
Brominated DBPs are the sum of CHBr3, BrCl2CH, Br2ClCH, BrAA, Br2AA, Br3AA, BrClAA, BrCl2AA, Br2ClAA
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Table 3
Distribution of DBP levels by site
Groups TTHM (μg/L) HAA5 (μg/L) HAA9 (μg/L) TOX (μg/L) Unaccounted TOX (μg/L) Chlorinated (μg/L) Brominated (μg/L)
Chlorinated DBP site
< 50th percentile 24.7–60.7 12.1–31.9 15.4–41.5 104–167.5 16.5–96.0 40.1–106.1 13–25.8
50th to 75th
percentile 60.7–75.9 31.9–41.1 41.5–54.3 167.5–192.5 96.0–109.9 106.1–125.8 25.8–31.9
75th to 90th
percentile 75.9–88.5 41.1–50.5 54.3–63.5 192.5–213 109.9–128.2 125.8–143.5 31.9–43.8
> 90th percentile 88.5–148.6 50.5–62.2 63.5–78.9 213–269 128.2–179.3 143.5–222.4 43.8–59.8
Brominated DBP site
< 50th percentile 26.6–58.9 13.2–20 30.4–44.7 111–183 34.7–127.7 50–87.95 41.8–77.6
50th to 75th
percentile 58.9–67.4 20–23.2 44.7–48.9 183–205 127.7–148.8 87.95–98.2 77.6–93.7
75th to 90th
percentile 67.4–80.6 23.2–26.2 48.9–54.7 205–234 148.8–169.5 98.2–106.5 93.7–106.9
> 90th percentile 80.6–165 26.2–53.1 54.7–98.9 234–290 169.5–223.5 106.5–238.1 103.9–168
Note: Taken from water system measures.
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Table 4
Adjusted Odds Ratios and 95% Confidence Intervals for Categorical and Continuous DBP Exposures –
Chlorinated DBP site
Outcome Exposure Variable





< 50th percentile 684/730/653 9179/9378/8481 1 1 1
50th to 75th
percentile 481/427/678 6290/5304/8685 1.02 (0.91,1.15) 1.02 (0.9,1.16) 1.01 (0.90,1.13)
75th to 90th
percentile 250/346/151 2949/4567/2144 1.12 (0.96,1.30) 0.97 (0.85,1.11) 0.91 (0.76,1.09)
> 90th percentile 128/40/61 1587/756/695 1.06 (0.87,1.29) 0.68 (0.49,0.94) 1.13 (0.86,1.49)
Continuous (per 10
μg/L) 1543 20005 1.01 (0.98,1.04) 0.96 (0.91,1.01) 1.00 (0.97,1.03)
PTB
a
< 50th percentile 1046/1050/948 11503/11784/10444 1 1 1
50th to 75th
percentile 570/538/855 6673/5718/9827 0.93 (0.84,1.04) 1.05 (0.94,1.17) 0.96 (0.87,1.05)
75th to 90th
percentile 341/430/224 3672/5140/2356 1.01 (0.89,1.14) 0.94 (0.84,1.06) 1.02 (0.88,1.19)
> 90th percentile 118/57/48 1423/629/644 0.91 (0.74,1.11) 1.04 (0.79,1.38) 0.84 (0.62,1.13)
Continuous (per 10
μg/L) 2075 23271 0.98 (0.95,1.00) 0.98 (0.94,1.03) 0.99 (0.97,1.01)
Very PTB
a
< 50th percentile 160/169/154 12389/12665/11238 1 1 1
50th to 75th
percentile 104/103/158 7139/6153/10524 1.12 (0.87,1.43) 1.25 (0.97,1.60) 1.09 (0.87,1.36)
75th to 90th
percentile 75/70/37 3938/5500/2543 1.43 (1.08,1.89) 0.96 (0.73,1.27) 1.02 (0.71,1.47)
> 90th percentile 17/14/7 1524/672/685 0.86 (0.52,1.43) 1.63 (0.94,2.85) 0.78 (0.36,1.67)
Continuous (per 10
μg/L) 356 24990 1.0 (0.95,1.07) 1.04 (0.93,1.16) 1.01 (0.96,1.07)
Note: Following Hoffman et al., third trimester exposures used for SGA analysis while second trimester exposures used for Preterm and very
Preterm analyses.
a
Adjusted for maternal age, maternal race, marital status, maternal education, tobacco use, alcohol use, and parity
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Table 5
Adjusted Odds Ratios and 95% Confidence Intervals for Categorical and Continuous DBP Exposures –
Brominated DBP site
Outcome Exposure Variable





< 50th percentile 103/124/97
b
1161/1278/1015
b 1 1 1
50th to 75th percentile 32/82/110
b
409/872/1185
b 0.81 (0.53,1.24) 1.00 (0.74,1.34) 0.98 (0.73,1.31)
75th to 90th percentile 107/39/45
b
1027/458/434
b 1.21 (0.91,1.63) 0.86 (0.59,1.26) 1.07 (0.73,1.57)
> 90th percentile 21/18/11
b
177/166/140
b 1.26 (0.76,2.08) 1.07 (0.62,1.83) 0.86 (0.44,1.68)




b 1.06 (0.96,1.16) 0.97 (0.59,1.59) 1.00 (0.99,1.01)
PTB
a
< 50th percentile 207/157/162 1667/1191/1462 1 1 1
50th to 75th percentile 41/144/170 312/1008/1276 1.16 (0.77,1.74) 1.17 (0.89,1.53) 1.16 (0.90,1.49)
75th to 90th percentile 137/78/60 934/771/332 1.19 (0.92,1.55) 0.74 (0.53,1.02) 1.69 (1.17,2.44)
> 90th percentile 16/22/9 196/139/39 0.77 (0.44,1.37) 1.29 (0.73,2.28) 1.99 (0.85,4.67)
Continuous (per 10 μg/
L) 401 3109 1.00 (0.92,1.09) 0.68 (0.42,1.12) 1.09 (1.03,1.16)
Very PTB
a
< 50th percentile 34/32/26 1840/1316/1598 1 1 1
50th to 75th percentile 14/29/31 339/1123/1415 2.36 (1.21,4.62) 1.16 (0.68,1.98) 1.29 (0.75,2.22)
75th to 90th percentile 23/11/16 1048/838/376 1.08 (0.62,1.90) 0.56 (0.27,1.14) 2.43 (1.22,4.84)
> 90th percentile 5/4/2003 207/157/45 1.63 (0.62,4.33) 1.23 (0.41,3.67) 4.17 (1.14,15.32)
Continuous (per 10μg/L) 76 3434 1.03 (0.86,1.23) 0.47 (0.17,1.30) 1.23 (1.09,1.39)
Note: Following Hoffman et al., third trimester exposures used for SGA analysis while second trimester exposures used for Preterm and very
Preterm analyses.
a
Adjusted for maternal age, maternal race, marital status, maternal education, tobacco use, alcohol use, and parity
b
The rounded average over imputations is used because SGA is defined by an imputed value.
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Table 6
Adjusted Odds Ratios and 95% Confidence Intervals for Categorical and Continuous DBP Exposures
stratified by chlorinated and brominated species of THMs and HAAs
Chlorinated DBP site Brominated DBP site











< 50th percentile 1 1 1 1
50th to 75th percentile 0.95 (0.84,1.07) 1.03 (0.91,1.16) 0.93 (0.68,1.26) 1.02 (0.72,1.43)
75th to 90th percentile 1.10 (0.95,1.28) 1.10 (0.94,1.27) 1.03 (0.69,1.54) 1.27 (0.93,1.75)
> 90th percentile 0.99 (0.79,1.24) 1.16 (0.96,1.41) 1.17 (0.77,1.78) 1.19 (0.71,2.00)
Continuous (per 10 μg/L) 1.00 (0.98,1.02) 1.05 (0.99,1.12) 1.02 (0.91,1.14) 1.05 (0.97,1.13)
PTB
c
< 50th percentile 1 1 1 1
50th to 75th percentile 0.94 (0.85,1.04) 1.04 (0.94,1.16) 1.18 (0.90,1.54) 0.78 (0.58,1.05)
75th to 90th percentile 1.06 (0.92,1.21) 0.97 (0.84,1.13) 1.49 (1.00,2.20) 1.05 (0.77,1.45)
> 90th percentile 0.85 (0.68,1.06) 1.15 (0.97,1.37) 0.89 (0.58,1.35) 0.83 (0.47,1.48)
Continuous (per 10 μg/L) 0.99 (0.97,1.01) 1.03 (0.97,1.09) 1.01 (0.90,1.12) 0.98 (0.91,1.05)
Very PTB
c
< 50th percentile 1 1 1 1
50th to 75th percentile 1.15 (0.91,1.45) 1.09 (0.86,1.39) 0.98 (0.56,1.73) 0.88 (0.48,1.61)
75th to 90th percentile 1.15 (0.84,1.57) 1.16 (0.84,1.62) 2.13 (1.08,4.21) 0.66 (0.32,1.37)
> 90th percentile 0.75 (0.43,1.33) 1.15 (0.77,1.72) 0.65 (0.24,1.75) 2.29 (1.01,5.21)
Continuous (per 10 μg/L) 1.01 (0.97,1.05) 1.08 (0.95,1.22) 1.04 (0.83,1.31) 0.98 (0.85,1.14)
Note: Following Hoffman et al., third trimester exposures used for SGA analysis while second trimester exposures used for Preterm and very
Preterm analyses.
a
Chlorinated DBPs are the sum of CHCl3, BrCl2CH, Br2ClCH, ClAA, Cl2AA, Cl3AA, BrClAA, BrCl2AA, Br2ClAA
b
Brominated DBPs are the sum of CHBr3, BrCl2CH, Br2ClCH, BrAA, Br2AA, Br3AA, BrClAA, BrCl2AA, Br2ClAA
c
Adjusted for maternal age, maternal race, marital status, maternal education, tobacco use, alcohol use, and parity
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Table 7
Adjusted Odds Ratios and 95% Confidence Intervals for Categorical and Continuous Unaccounted TOX
exposure
Chlorinated Site Brominated Site
Exposure Variable Number of Cases/Controls Unaccounted TOX Number of Cases/Controls Unaccounted TOX
Term-SGA
a
< 50th percentile 728/9305 1 88/946 1
50th to 75th
percentile 743/9665 0.99 (0.89,1.11) 149/1616 0.98 (0.73,1.32)
> 75th percentile 75/1100 0.877 (0.69,1.12) 49/510 1.06 (0.71,1.57)
> 90th percentile 0/0 - 3/51 0.90 (0.27,3.00)
Continuous (per
10 μg/L) 1543/20005 0.99 (0.93,1.05) 289/3123 0.98 (0.91,1.06)
PTB
a
< 50th percentile 1063/12300 1 219/1948 1
50th to 75th
percentile 1012/11426 1.03 (0.94,1.13) 316/2489 1.19 (0.92,1.55)
> 75th percentile 126/1135 1.24 (1.02,1.52) 121/827 1.66 (1.12,2.45)
Continuous (per
10 μg/L) 2075/23271 1.06 (1.00,1.12) 656/5264 1.11 (1.04,1.19)
Very PTB
a
< 50th percentile 184/13179 1 31/2136 1
50th to 75th
percentile 166/12272 0.96 (0.77,1.20) 56/2749 1.80 (1.00,3.24)
> 75th percentile 31/1230 1.681 (1.13,2.51) 32/916 3.62 (1.75,7.52)
Continuous (per
10 μg/L) 356/24990 1.02 (0.90,1.16) 119/5801 1.30 (1.13,1.50)
Note: Following Hoffman et al., third trimester exposures used for SGA analysis while second trimester exposures used for Preterm and very
Preterm analyses.
a
Adjusted for maternal age, maternal race, marital status, maternal education, tobacco use, alcohol use, and parity
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